InspireMD (NASDAQ: NSPR)
$2.00
(4.4%)
$0.08
Price as of April 26, 2024, 3:23 p.m. ET
InspireMD Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
InspireMD Company Info
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.